Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Kyverna Therapeutics, Inc. (KYTX)
Portfolio Pulse from
Glancy Prongay & Murray LLP has announced a deadline for investors to file a lead plaintiff motion in a class action lawsuit against Kyverna Therapeutics, Inc. The lawsuit concerns investors who acquired Kyverna's stock during its February 2024 IPO.
December 19, 2024 | 6:30 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Kyverna Therapeutics is facing a class action lawsuit related to its February 2024 IPO. Investors have until February 7, 2025, to file a lead plaintiff motion.
The class action lawsuit against Kyverna Therapeutics is likely to negatively impact its stock price in the short term due to potential legal liabilities and investor concerns. The deadline for filing a lead plaintiff motion is a critical date for investors.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100